Kyntra Bio Non-Current Deferred Revenue (Quarterly) Analysis

Kyntra Bio, Inc. (KYNB)

9.12 +0.05 (+0.55%) USD | NASDAQ | Jan 13, 16:00

9.12 0.00 (0.00%) After-Hours: 18:14

View Non-Current Deferred Revenue (Quarterly) for KYNB.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Non-Current Deferred Revenue (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Non-Current Deferred Revenue (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Non-Current Deferred Revenue (Quarterly) Benchmarks

Start Trial

Assertio Holdings, Inc.	--
Perspective Therapeutics, Inc.	Upgrade
Skye Bioscience, Inc.	--
Theravance Biopharma, Inc.	--
Myomo, Inc.	--